Skip to main content
. 1999 Jan 25;1999(1):CD001361. doi: 10.1002/14651858.CD001361

Kissling 1985.

Methods Allocation: randomised, flip of a coin. 
 Blindness: double. 
 Duration: 6 months. 
 Statistics: last observation carried forward.
Participants Diagnosis: schizophrenia/ schizoaffective psychosis (DSM III). 
 History: on oral medication, need depot treatment for >6 months, informed consent given. 
 N=54. 
 Age: ˜ 30 years (SD ˜11). 
 Sex: 24 M, 7 F.
Interventions 1. Haloperidol decanoate: dose mean 80mg/ injection (actual dose given 50mg), monthly. N=32. 
 2. Fluphenazine decanoate: dose mean 21mg/ injection (actual dose given 25mg), every 2 weeks. N=22.
Outcomes Leaving the study early.
Unable to use ‐ 
 Mental state (BPRS).* 
 Additional medication (anticholinergics).* 
 Side effects (EPMS, DOTES, STESS).* 
 Physiological Measures (serum levels ‐ non clinical outcomes, data not usable).*
Notes *The drop out rate after 6 months for FD=60%, HD=30%.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear